SECOND EXTENSION - GRANTED
granted
on 16 Jul 2024
Last Applicant/ Owned by
1500 District Avenue
Burlington
MA
01803
Serial Number
97560126 filed on 23rd Aug 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ROLSIGMA
Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocki Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97560126
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 323191-20000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Jul 2024 | SOU EXTENSION 2 GRANTED |
| 16th Jul 2024 | SOU EXTENSION 2 FILED |
| 16th Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
| 11th Jul 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 11th Jul 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 11th Jul 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 11th Jul 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 14th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 13th Feb 2024 | SOU EXTENSION 1 GRANTED |